{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:47:46Z","timestamp":1785534466966,"version":"3.56.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40272-019-00331-z","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T02:06:21Z","timestamp":1556244381000},"page":"113-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and Safety of Oral Paracetamol vs. Oral Ibuprofen in the Treatment of Symptomatic Patent Ductus Arteriosus in Premature Infants"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-153X","authenticated-orcid":false,"given":"Birol","family":"Karabulut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebnem","family":"Paytoncu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"issue":"4","key":"331_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000092870","volume":"89","author":"RI Clyman","year":"2006","unstructured":"Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate. 2006;89(4):330\u20135.","journal-title":"Biol Neonate"},{"key":"331_CR2","first-page":"1","volume":"23","author":"JG Weinberg","year":"2015","unstructured":"Weinberg JG, Evans FJ, Burns KM, Pearson GD, Kaltman JR. Surgical ligation of patent ductus arteriosus in premature infants: trends and practice variation. Cardiol Young. 2015;23:1\u20138.","journal-title":"Cardiol Young"},{"issue":"4","key":"331_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jpeds.2012.05.007","volume":"161","author":"L Mirea","year":"2012","unstructured":"Mirea L, Sankaran K, Seshia M, et al. Treatment of patent ductus arteriosus and neonatal mortality\/morbidities: adjustment for treatment selection bias. J Pediatr. 2012;161(4):689\u2013694e1.","journal-title":"J Pediatr"},{"issue":"2","key":"331_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/j.semperi.2011.09.020","volume":"36","author":"A Sehgal","year":"2012","unstructured":"Sehgal A, McNamara PJ. The ductus arteriosus: a refined approach. Semin Perinatol. 2012;36(2):105\u201313.","journal-title":"Semin Perinatol"},{"issue":"4","key":"331_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/jp.2010.3","volume":"30","author":"WE Benitz","year":"2010","unstructured":"Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010;30(4):241\u201352. \n                    https:\/\/doi.org\/10.1038\/jp.2010.3\n                    \n                  .","journal-title":"J Perinatol"},{"issue":"4","key":"331_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/157488412803305830","volume":"7","author":"G Demirel","year":"2012","unstructured":"Demirel G, Erdeve O, Dilmen U. Pharmacological management of PDA: oral versus intravenous medications. Curr Clin Pharmacol. 2012;7(4):263\u201370.","journal-title":"Curr Clin Pharmacol"},{"issue":"4","key":"331_CR7","doi-asserted-by":"publisher","first-page":"F279","DOI":"10.1136\/archdischild-2011-300532","volume":"97","author":"O Erdeve","year":"2012","unstructured":"Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2012;97(4):F279\u201383. \n                    https:\/\/doi.org\/10.1136\/archdischild-2011-300532\n                    \n                  .","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"331_CR8","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1542\/peds.2009-0003","volume":"123","author":"O Erdeve","year":"2009","unstructured":"Erdeve O, Gokmen T, Altug N, Dilmen U. Oral versus intravenous ibuprofen: which is better in closure of patent ductus arteriosus? Pediatrics. 2009;123:763.","journal-title":"Pediatrics"},{"key":"331_CR9","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00467-008-0835-9","volume":"23","author":"O Erdeve","year":"2008","unstructured":"Erdeve O, Sarici SU, Sari E, Gok F. Oral ibuprofen-induced acute renal failure in a preterm infant. Pediatr Nephrol. 2008;23:1565\u20137.","journal-title":"Pediatr Nephrol"},{"key":"331_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3109\/14767058.2012.755162","volume":"26","author":"S Yurttutan","year":"2013","unstructured":"Yurttutan S, Oncel MY, Arayici S, Uras N, Altug N, Erdeve O, et al. A different first choice drug in the medical management of patent ductus arteriosus: oral paracetamol. J Matern Fetal Neonatal Med. 2013;26:825\u20137.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"331_CR11","doi-asserted-by":"publisher","unstructured":"Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2015;(3):CD010061. \n                    https:\/\/doi.org\/10.1002\/14651858.cd010061.pub3\n                    \n                  .","DOI":"10.1002\/14651858.cd010061.pub3"},{"issue":"Suppl 1","key":"331_CR12","first-page":"S76","volume":"53","author":"N K\u00f6ksal","year":"2018","unstructured":"K\u00f6ksal N, Ayg\u00fcn C, Uras N. Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants. Turk Pediatri Ars. 2018;53(Suppl 1):S76\u201387.","journal-title":"Turk Pediatri Ars"},{"key":"331_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0031-3955(16)34975-6","volume":"33","author":"MC Walsh","year":"1986","unstructured":"Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin N Am. 1986;33:179\u2013201.","journal-title":"Pediatr Clin N Am"},{"key":"331_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","volume":"92","author":"LA Papile","year":"1978","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500\u00a0gm. J Pediatr. 1978;92:529\u201334.","journal-title":"J Pediatr"},{"key":"331_CR15","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991\u20139.","journal-title":"Arch Ophthalmol"},{"key":"331_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms19071861","volume":"2018","author":"YC Hung","year":"1861","unstructured":"Hung YC, Yeh JL, Hsu JH. Molecular mechanisms for regulating postnatal ductus arteriosus closure. Int J Mol Sci. 1861;2018:19. \n                    https:\/\/doi.org\/10.3390\/ijms19071861\n                    \n                  .","journal-title":"Int J Mol Sci"},{"key":"331_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/B978-1-4377-0134-0.10054-X","volume-title":"Avery\u2019s diseases of the newborn","author":"RI Clyman","year":"2012","unstructured":"Clyman RI. Patent ductus arteriosus in the preterm infant. In: Gleason CA, Devaskar S, editors. Avery\u2019s diseases of the newborn. 9th ed. Philadelphia: Saunders; 2012. p. 751\u201361.","edition":"9"},{"key":"331_CR18","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1542\/peds.2009-3506","volume":"125","author":"SE Hamrick","year":"2010","unstructured":"Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010;125:1020\u201330.","journal-title":"Pediatrics"},{"key":"331_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1056\/NEJM197609022951004","volume":"295","author":"MA Heymann","year":"1976","unstructured":"Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med. 1976;295:530\u20133.","journal-title":"N Engl J Med"},{"key":"331_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJM197609022951003","volume":"295","author":"WF Friedman","year":"1976","unstructured":"Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med. 1976;295:526\u20139.","journal-title":"N Engl J Med"},{"key":"331_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0090-6980(89)90001-4","volume":"37","author":"K Gr\u00e8en","year":"1989","unstructured":"Gr\u00e8en K, Drvota V, Vesterqvist O. Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). Prostaglandins. 1989;37:311\u20135.","journal-title":"Prostaglandins"},{"key":"331_CR22","doi-asserted-by":"publisher","first-page":"13926","DOI":"10.1073\/pnas.162468699","volume":"99","author":"NV Chandrasekharan","year":"2002","unstructured":"Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA. 2002;99:13926\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"331_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1096\/fj.04-2437fje","volume":"19","author":"R Lucas","year":"2005","unstructured":"Lucas R, Warner TD, Vojnovic I, Mitchell JA. Cellular mechanisms of acetaminophen: role of cyclooxygenase. FASEB J. 2005;19:635\u20137.","journal-title":"FASEB J"},{"key":"331_CR24","doi-asserted-by":"publisher","first-page":"24019","DOI":"10.1074\/jbc.270.41.24019","volume":"270","author":"RJ Kulmacz","year":"1995","unstructured":"Kulmacz RJ, Wang LH. Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2. J Biol Chem. 1995;270:24019\u201323.","journal-title":"J Biol Chem"},{"key":"331_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","volume":"21","author":"GG Graham","year":"2013","unstructured":"Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21:201\u201332.","journal-title":"Inflammopharmacology"},{"key":"331_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00228-008-0586-3","volume":"65","author":"R Antonucci","year":"2009","unstructured":"Antonucci R, Cuzzolin L, Arceri A, Dess\u00ec A, Fanos V. Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus. Eur J Clin Pharmacol. 2009;65:223\u201330.","journal-title":"Eur J Clin Pharmacol"},{"key":"331_CR27","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3892\/etm.2016.3676","volume":"12","author":"B Yang","year":"2016","unstructured":"Yang B, Gao X, Ren Y, Wang Y, Zhang Q. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial. Exp Ther Med. 2016;12:2531\u20136.","journal-title":"Exp Ther Med."},{"key":"331_CR28","first-page":"CD010061","volume":"3","author":"A Ohlsson","year":"2015","unstructured":"Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants. Cochrane Database Syst Rev. 2015;3:CD010061.","journal-title":"Cochrane Database Syst Rev"},{"key":"331_CR29","doi-asserted-by":"publisher","first-page":"e77888","DOI":"10.1371\/journal.pone.0077888","volume":"8","author":"D Dang","year":"2013","unstructured":"Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PloS One. 2013;8:e77888.","journal-title":"PloS One"},{"key":"331_CR30","first-page":"231","volume":"52","author":"V Fanos","year":"2010","unstructured":"Fanos V, Antonucci R, Zaffanello M. Ibuprofen and acute kidney injury in the newborn. Turk J Pediatr. 2010;52:231\u20138.","journal-title":"Turk J Pediatr"},{"key":"331_CR31","first-page":"54","volume":"44","author":"F Tiker","year":"2007","unstructured":"Tiker F, Yildirim SV. Acute renal impairment after oral ibuprofen for medical closure of patent ductus arteriosus. Indian Pediatr. 2007;44:54\u20135.","journal-title":"Indian Pediatr"},{"key":"331_CR32","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00467-008-0835-9","volume":"23","author":"O Erdeve","year":"2008","unstructured":"Erdeve O, Sarici SU, Sari E, Gok F. Oral-ibuprofen-induced acute renal failure in a preterm infant. Pediatr Nephrol Berl Ger. 2008;23:1565\u20137.","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"6","key":"331_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1442-200X.2003.01797.x","volume":"45","author":"PH Su","year":"2003","unstructured":"Su PH, Chen JY, Su CM, et al. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int. 2003;45(6):665\u201370.","journal-title":"Pediatr Int"},{"issue":"2","key":"331_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00467-009-1349-9","volume":"25","author":"R Vieux","year":"2010","unstructured":"Vieux R, Desandes R, Boubred F, et al. Ibuprofen in very preterm infants impairs renal function for the first month of life. Pediatr Nephrol. 2010;25(2):267\u201374.","journal-title":"Pediatr Nephrol"},{"key":"331_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00431-016-2830-7","volume":"176","author":"AE El-Mashad","year":"2017","unstructured":"El-Mashad AE, El-Mahdy H, El Amrousy D, et al. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr. 2017;176:233\u201340.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"331_CR36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1542\/peds.2008-2433","volume":"124","author":"E Zecca","year":"2009","unstructured":"Zecca E, Romagnoli C, De Carolis MP, Costa S, Marra R, De Luca D. Does ibuprofen increase neonatal hyperbilirubinemia? Pediatrics. 2009;124(2):480\u20134. \n                    https:\/\/doi.org\/10.1542\/peds.2008-2433\n                    \n                  .","journal-title":"Pediatrics"},{"issue":"1","key":"331_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1651-2227.2008.01007.x","volume":"98","author":"C Rheinlaender","year":"2009","unstructured":"Rheinlaender C, Helfenstein D, Walch E, et al. Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants. Acta Paediatr. 2009;98(1):36\u201342.","journal-title":"Acta Paediatr"},{"key":"331_CR38","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jpeds.2003.11.027","volume":"144","author":"CE Ahlfors","year":"2004","unstructured":"Ahlfors CE. Effect of ibuprofen on bilirubin\u2013albumin binding. J Pediatr. 2004;144:386\u20138.","journal-title":"J Pediatr"},{"key":"331_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1600-0773.1996.tb00012.x","volume":"79","author":"C Cooper-Peel","year":"1996","unstructured":"Cooper-Peel C, Brodersen R, Robertson A. Does ibuprofen affect bilirubin\u2013albumin binding in newborn infant serum. Pharmacol Toxicol. 1996;79:297\u20139.","journal-title":"Pharmacol Toxicol"},{"key":"331_CR40","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1203\/PDR.0b013e3181da7578","volume":"67","author":"HT Soligard","year":"2010","unstructured":"Soligard HT, Nilsen OG, Bratlid D. Displacement of bilirubin from albumin by ibuprofen in vitro. Pediatr Res. 2010;67:614\u20138.","journal-title":"Pediatr Res"},{"key":"331_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.earlhumdev.2010.04.006","volume":"86","author":"C Diot","year":"2010","unstructured":"Diot C, Kibleur Y, Desfrere L. Effect of ibuprofen on bilirubin\u2013albumin binding in vitro at concentrations observed during treatment of patent ductus arteriosus. Early Hum Dev. 2010;86:315\u20137.","journal-title":"Early Hum Dev"},{"key":"331_CR42","first-page":"40","volume":"41","author":"M Wu","year":"2010","unstructured":"Wu M, Wan J. COX-3: is it the target of acetaminophen? Prog Physiol Sci. 2010;41:40\u20132.","journal-title":"Prog Physiol Sci"},{"key":"331_CR43","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jpedsurg.2014.01.029","volume":"49","author":"KS Walker","year":"2014","unstructured":"Walker KS, Matheson PJ, Galganski LA, Garrison RN, Downard CD. Application of prostaglandin E2 improves ileal blood flow in NEC. J Pediatr Surg. 2014;49:945\u20139 (discussion 949).","journal-title":"J Pediatr Surg"},{"issue":"6","key":"331_CR44","doi-asserted-by":"publisher","first-page":"e1618","DOI":"10.1542\/peds.2011-0359","volume":"128","author":"C Hammerman","year":"2011","unstructured":"Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics. 2011;128(6):e1618\u201321.","journal-title":"Pediatrics"},{"key":"331_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/1060028014557564","volume":"49","author":"J Le","year":"2015","unstructured":"Le J, Gales MA, Gales BJ. Acetaminophen for patent ductus arteriosus. Ann Pharmacother. 2015;49:241\u20136.","journal-title":"Ann Pharmacother"},{"key":"331_CR46","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/archdischild-2013-303688","volume":"98","author":"K Allegaert","year":"2013","unstructured":"Allegaert K, Anderson B, Simons S, van Overmeire B. Paracetamol to induce ductus arteriosus closure: is it valid? Arch Dis Child. 2013;98:462\u20136.","journal-title":"Arch Dis Child"},{"key":"331_CR47","doi-asserted-by":"publisher","first-page":"F94","DOI":"10.1136\/archdischild-2012-302044","volume":"98","author":"MY Oncel","year":"2013","unstructured":"Oncel MY, Yurttutan S, Uras N, Altug N, Ozdemir R, Ekmen S, Erdeve O, Dilmen U. An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants. Arch Dis Child Fetal Neonatal Ed. 2013;98:F94.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"331_CR48","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/jp.2014.96","volume":"34","author":"E Nadir","year":"2014","unstructured":"Nadir E, Kassem E, Foldi S, Hochberg A, Feldman M. Paracetamol treatment of patent ductus arteriosus in preterm infants. J Perinatol. 2014;34:748\u20139.","journal-title":"J Perinatol"},{"key":"331_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/2249-4847.109245","volume":"2","author":"R Sinha","year":"2013","unstructured":"Sinha R, Negi V, Dalal SS. An interesting observation of PDA closure with oral paracetamol in preterm neonates. J Clin Neonatol. 2013;2:30\u20132.","journal-title":"J Clin Neonatol"},{"key":"331_CR50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00246-013-0770-9","volume":"35","author":"OM Ozdemir","year":"2014","unstructured":"Ozdemir OM, Do\u011fan M, K\u00fc\u00e7\u00fckta\u015f\u00e7\u0131 K, Ergin H, Sahin O. Paracetamol therapy for patent ductus arteriosus in premature infants: a chance before surgical ligation. Pediatr Cardiol. 2014;35:276\u20139.","journal-title":"Pediatr Cardiol"},{"key":"331_CR51","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jpeds.2013.11.008","volume":"164","author":"MY Oncel","year":"2014","unstructured":"Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, Canpolat FE, Dilmen U. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr. 2014;164:510\u2013514.e.1.","journal-title":"J Pediatr"},{"issue":"4","key":"331_CR52","doi-asserted-by":"publisher","first-page":"e3975","DOI":"10.5812\/ijp.3975","volume":"26","author":"MM Bagheri","year":"2016","unstructured":"Bagheri MM, Niknafs P, Sabsevari F, Torabi MH, Bijari BB, Noroozi E, Mossavi H. Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus. Iran J Pediatr. 2016;26(4):e3975.","journal-title":"Iran J Pediatr"},{"key":"331_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1525354","author":"B Balachander","year":"2018","unstructured":"Balachander B, Mondal N, Bhat V, Adhisivam B, Kumar M, Satheesh S, Thulasingam M. Comparison of efficacy of oral paracetamol versus ibuprofen for PDA closure in preterms\u2014a prospective randomized clinical trial. J Matern Fetal Neonatal Med. 2018. \n                    https:\/\/doi.org\/10.1080\/14767058.2018.1525354\n                    \n                  .","journal-title":"J Matern Fetal Neonatal Med"},{"key":"331_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1470235","author":"RA El-Farrash","year":"2018","unstructured":"El-Farrash RA, El Shimy MS, El-Sakka AS, Ahmed MG, Abdel-Moez DG. Efficacy and safety of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Matern Fetal Neonatal Med. 2018. \n                    https:\/\/doi.org\/10.1080\/14767058.2018.1470235\n                    \n                  .","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"331_CR55","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1177\/0300060517722698","volume":"46","author":"M Al-Lawama","year":"2017","unstructured":"Al-Lawama M, Alammori I, Abdelghani T, Badran E. Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus. J Int Med Res. 2017;46(2):811\u2013818.","journal-title":"J Int Med Res"},{"key":"331_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000348568","volume":"104","author":"KS Tekgunduz","year":"2013","unstructured":"Tekgunduz KS, Ceviz N, Demirelli Y, Olgun H, Caner I, Sahin IO, et al. Intravenous paracetamol for patent ductus arteriosus in premature infants\u2014a lower dose is also effective. Neonatology. 2013;104:6\u20137.","journal-title":"Neonatology"},{"key":"331_CR57","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000352068","volume":"104","author":"S Alan","year":"2013","unstructured":"Alan S, Kahvecioglu D, Erdeve O, Atasay B, Arsan S. Is paracetamol a useful treatment for ibuprofen-resistant patent ductus arteriosus? Neonatology. 2013;104:168\u20139.","journal-title":"Neonatology"},{"key":"331_CR58","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1076\/ceyr.27.5.309.17222","volume":"27","author":"J Sharma","year":"2003","unstructured":"Sharma J, Barr SM, Geng Y, Yun Y, Higgins RD. Ibuprofen improves oxygen-induced retinopathy in a mouse model. Curr Eye Res. 2003;27:309\u201314.","journal-title":"Curr Eye Res"},{"issue":"1","key":"331_CR59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/toxsci\/kft329","volume":"138","author":"H Viberg","year":"2014","unstructured":"Viberg H, Eriksson P, Gordh T, Fredriksson A. Paracetamol (acetaminophen) administration during neonatal brain development affects cognitive function and alters its analgesic and anxiolytic response in adult male mice. Toxicol Sci. 2014;138(1):139\u201347.","journal-title":"Toxicol Sci"},{"issue":"12","key":"331_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1476-069X-12-41","volume":"9","author":"AZ Bauer","year":"2013","unstructured":"Bauer AZ, Kriebel D. Prenatal and perinatal analgesic exposure and autism: an ecological link. Environ Health. 2013;9(12):41.","journal-title":"Environ Health"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00331-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-019-00331-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00331-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T23:08:05Z","timestamp":1587769685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-019-00331-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1007\/s40272-019-00331-z","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"26 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"B. Karabulut, S. Paytoncu have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}